These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 1737847)

  • 21. Y-position cysteine substitution in type I collagen (alpha1(I) R888C/p.R1066C) is associated with osteogenesis imperfecta/Ehlers-Danlos syndrome phenotype.
    Cabral WA; Makareeva E; Letocha AD; Scribanu N; Fertala A; Steplewski A; Keene DR; Persikov AV; Leikin S; Marini JC
    Hum Mutat; 2007 Apr; 28(4):396-405. PubMed ID: 17206620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of point mutations in type I collagen by RNase digestion of RNA/RNA hybrids.
    Grange DK; Gottesman GS; Lewis MB; Marini JC
    Nucleic Acids Res; 1990 Jul; 18(14):4227-36. PubMed ID: 1696002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a type I collagen alpha 2(I) glycine-586 to valine substitution in osteogenesis imperfecta type IV. Detection of the mutation and prenatal diagnosis by a chemical cleavage method.
    Bateman JF; Hannagan M; Chan D; Cole WG
    Biochem J; 1991 Jun; 276 ( Pt 3)(Pt 3):765-70. PubMed ID: 2064612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteogenesis imperfecta type IV. Detection of a point mutation in one alpha 1(I) collagen allele (COL1A1) by RNA/RNA hybrid analysis.
    Marini JC; Grange DK; Gottesman GS; Lewis MB; Koeplin DA
    J Biol Chem; 1989 Jul; 264(20):11893-900. PubMed ID: 2745420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutation in the carboxy-terminal propeptide of the Pro alpha 1(I) chain of type I collagen in a child with severe osteogenesis imperfecta (OI type III): possible implications for protein folding.
    Oliver JE; Thompson EM; Pope FM; Nicholls AC
    Hum Mutat; 1996; 7(4):318-26. PubMed ID: 8723681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endoplasmic reticulum-mediated quality control of type I collagen production by cells from osteogenesis imperfecta patients with mutations in the pro alpha 1 (I) chain carboxyl-terminal propeptide which impair subunit assembly.
    Lamandé SR; Chessler SD; Golub SB; Byers PH; Chan D; Cole WG; Sillence DO; Bateman JF
    J Biol Chem; 1995 Apr; 270(15):8642-9. PubMed ID: 7721766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequence of normal canine COL1A1 cDNA and identification of a heterozygous alpha1(I) collagen Gly208Ala mutation in a severe case of canine osteogenesis imperfecta.
    Campbell BG; Wootton JA; MacLeod JN; Minor RR
    Arch Biochem Biophys; 2000 Dec; 384(1):37-46. PubMed ID: 11147834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gly802Asp substitution in the pro alpha 2(I) collagen chain in a family with recurrent osteogenesis imperfecta due to paternal mosaicism.
    Lund AM; Schwartz M; Raghunath M; Steinmann B; Skovby F
    Eur J Hum Genet; 1996; 4(1):39-45. PubMed ID: 8800927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serine for glycine substitutions in type I collagen in two cases of type IV osteogenesis imperfecta (OI). Additional evidence for a regional model of OI pathophysiology.
    Marini JC; Lewis MB; Wang Q; Chen KJ; Orrison BM
    J Biol Chem; 1993 Feb; 268(4):2667-73. PubMed ID: 8094076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical variability of osteogenesis imperfecta reflecting molecular heterogeneity: cysteine substitutions in the alpha 1(I) collagen chain producing lethal and mild forms.
    Steinmann B; Nicholls A; Pope FM
    J Biol Chem; 1986 Jul; 261(19):8958-64. PubMed ID: 3722184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Gly238Ser substitution in the alpha 2 chain of type I collagen results in osteogenesis imperfecta type III.
    Rose NJ; Mackay K; Byers PH; Dalgleish R
    Hum Genet; 1995 Feb; 95(2):215-8. PubMed ID: 7860070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substitution of serine for glycine 883 in the triple helix of the pro alpha 1 (I) chain of type I procollagen produces osteogenesis imperfecta type IV and introduces a structural change in the triple helix that does not alter cleavage of the molecule by procollagen N-proteinase.
    Lightfoot SJ; Atkinson MS; Murphy G; Byers PH; Kadler KE
    J Biol Chem; 1994 Dec; 269(48):30352-7. PubMed ID: 7982948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A dominant mutation in the COL1A1 gene that substitutes glycine for valine causes recurrent lethal osteogenesis imperfecta.
    Bonaventure J; Cohen-Solal L; Lasselin C; Maroteaux P
    Hum Genet; 1992 Aug; 89(6):640-6. PubMed ID: 1511982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A de novo G+1-->A mutation at the alpha 2(I) exon 16 splice donor site causes skipping of exon 16 in the cDNA of one allele of an OI type IV proband.
    Filie JD; Orrison BM; Wang Q; Lewis MB; Marini JC
    Hum Mutat; 1993; 2(5):380-8. PubMed ID: 8257992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteogenesis imperfecta and type-I collagen mutations. A lethal variant caused by a Gly910-->Ala substitution in the alpha 1 (I) chain.
    Valli M; Sangalli A; Rossi A; Mottes M; Forlino A; Tenni R; Pignatti PF; Cetta G
    Eur J Biochem; 1993 Feb; 211(3):415-9. PubMed ID: 7679635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of different cysteine for glycine substitutions within alpha 2(I) chains. Evidence of distinct structural domains within the type I collagen triple helix.
    Wenstrup RJ; Shrago-Howe AW; Lever LW; Phillips CL; Byers PH; Cohn DH
    J Biol Chem; 1991 Feb; 266(4):2590-4. PubMed ID: 1990009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An intronic deletion leading to skipping of exon 21 of COL1A2 in a boy with mild osteogenesis imperfecta.
    Superti-Furga A; Raghunath M; Pistone FM; Romano C; Steinmann B
    Connect Tissue Res; 1993; 29(1):31-40. PubMed ID: 8339544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substitution of cysteine for glycine-946 in the alpha 1(I) chain of type I procollagen causes lethal osteogenesis imperfecta.
    Kurosaka D; Hattori S; Hori H; Yamaguchi N; Hasegawa T; Akimoto H; Nagai Y
    J Biochem; 1994 May; 115(5):853-7. PubMed ID: 7961597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal procollagen synthesis in fibroblasts from three patients of the same family with a severe form of osteogenesis imperfecta (type III).
    Bonaventure J; Cohen-Solal L; Lasselin C; Allain JC; Maroteaux P
    Biochim Biophys Acta; 1986 Oct; 889(1):23-34. PubMed ID: 3768427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type I procollagens containing substitutions of aspartate, arginine, and cysteine for glycine in the pro alpha 1 (I) chain are cleaved slowly by N-proteinase, but only the cysteine substitution introduces a kink in the molecule.
    Lightfoot SJ; Holmes DF; Brass A; Grant ME; Byers PH; Kadler KE
    J Biol Chem; 1992 Dec; 267(35):25521-8. PubMed ID: 1460046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.